Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2006; 12(34): 5532-5535
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5532
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5532
Table 1 Characteristics of 171 HCV infection patients with SVR-6 (n = 171)
| Characteristics | |
| Age (yr) | |
| Mean ± SD | 48 ± 10.5 |
| Range | 21-75 |
| Sex | |
| Male | 91 (53%) |
| Female | 80 (47%) |
| Follow up (mo) | |
| Mean ± SD | 35.38 ± 22.2 |
| Range | 8-134 |
| Genotype | |
| 1 | 48 (28.1%) |
| 3 | 107 (62.6%) |
| 6 | 6 (3.5%) |
| Unclassified | 10 (5.8%) |
| Cirrhosis (before therapy) | 27 (25.8%) |
| HCV viral load (copies/mL) | 1 000-136 000 000 |
| Median HCV viral load | 903 000 |
Table 2 Features of the three hepatocellular carcinoma patients
| Case1 | Case 2 | Case 3 | |
| Age (yr) | 50 | 75 | 63 |
| Sex | Male | Male | Male |
| Previous cirrhosis | Yes | Yes | No |
| Onset after the end of treatment (mo) | 14 | 18 | 29 |
| Alfa-fetoprotein (IU/mL) | 433.7 | 2.09 | 21.59 |
| Size at first detection | 3 cm | 1.5 cm | 1 cm, 3 lesions |
- Citation: Chavalitdhamrong D, Tanwandee T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 2006; 12(34): 5532-5535
- URL: https://www.wjgnet.com/1007-9327/full/v12/i34/5532.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i34.5532